Reporting of "LSIL with ASC-H" on cervicovaginal smears: Is it a valid category to predict cases with HSIL follow-up?

Recently it has been shown that there is a 15-30% risk of associated cervical intraepithelial neoplasia (CIN 2-3 or greater) for a low-grade squamous intraepithelial lesion (LSIL) diagnosis. We tried to define a subgroup of "LSIL with atypical squamous cells of undetermined significance. High-grade squamous intraepithelial lesion (LASC-H)" in cervicovaginal screening which may aid in predicting the cases associated with high risk cannot be ruled out. In the years between 2001 and 2003 a total of 21,342 cervicovaginal smears were evaluated. The smears with pure LSIL and LASC-H diagnosis which had histologic follow-up were selected. The cases with diagnosis of LASC-H contained numerous typical cells of LSIL and only a few cells with features suggesting high-grade squamous intraepithelial lesion (HSIL). Eight (61%) of 13 cases with a diagnosis of LASC-H but three (11%) of 27 cases with a diagnosis of pure LSIL resulted in CIN 2-3 histology (p < 0.05). Diagnosis of LASC-H may be a valid diagnostic category in distinguishing patients with LSIL that would have HSIL in follow-up.

Cervical intraepithelial neoplasia; LSIL; ASC-H

[1] The ASCUS-LSIL Triage Study (ALTS) Group: "A randomized trial on the management of low-grade intraepithelial lesion cytology interpretations". Am. J. Obstet. Gynecol., 2003, 188, 1393.

[2] Law K.S., Chang T.C., Hsueh S., Jung S.M., Tseng C.J., Lai C.H.: "High prevalence of high grade squamous intraepithelial lesions and microinvasive carcinoma in women with a cytologic diagnosis of low grade squamous intraepithelial lesions". J. Reprod. Med., 2001, 46, 61.

[3] Fallani M.G., Penna C., Fambrini M., Marchionni M.: "Cervical cytologic reports of ASCUS and LSIL. Cyto-histological correlation and implication for management". Minerva Ginecol., 2002, 54, 263.

[4] Lytwyn A., Sellors J.W., Mahony J.B. et al. (The HPV effectiveness in Low-grade Paps Study No 1 Group): "Comparison of human papilloma virus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a radomized trial". C.M.A.J., 2000, 163, 701.

[5] Kurman R.J., Henson D.E., Herbst A.L., Nosier K.L., Schifman M.E.: "Interim guidelines for management of abnormal cervical cytology: the 1992 National Cancer Insl!tute work-shop". JAMA. 1994, 271, 1866.

[6] Solomon D., Davey D., Kurman R. et al.: " The 2001 Bethesda system: terminology for reporting results of cervical cytology". JAMA, 2002, 287, 2114.

[7] Malik S.N., Wilkinson E.S., Drew P.A. et al.: "Do qualifiers of ASCUS distinguish between low and high risk patients?". Acta Cytol., 1999, 43, 376.

[8] Genest D.R., Dean B., Lee L.R. et al.: "Qualifiying the cytologic diagnosis of "atypical squamous cells od undetermined signifi cance" affects the predictive vakue of squamous intraepithelial lesion on subsequent biopsy". Arch. Pathol. Lab. Med., 1998, 122, 338.

[9] Schoolland M., Sterrett G.F., Knowless S.A.S. et al.: "The inconelusive- possible high grade epithelial abnormality" category in Papanicolaou smear reporting". Cancer, 1998, 84, 208.

[10] Sherman M.E., Tabbara S.O., Scott D.R. et al.: "ASCUS rule out HSIL: cytologic features, histologic correlates and human papillomavirus detection". Mod. Pathol., 1999, 12, 335.

[11] Quddus M.R., Sung CJ., Steinhoff M.M. et al.: "Atypical squamous metaplastic cells: reproducibility,outcome and diagnostic features of Thin Prep Pap test". Cancer, 2001, 93, 16.

[12] Sherman M.E., Solomon D., Schiffman M., for the ALTS Group. "Qualification of ASCUS, A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL triage study". Am. J. Clin. Pathol., 2001, 116, 386.

[13] McGrath C.M., Kurtis J.D., Gordon H.Y.: "Evaluation of mild-tomoderate dysplasia on cervical-endocervical (Pap) smear: a subgroup of patients who brigde LSIL and HSIL". Diagn. Cytopathol., 2000, 23, 245.